Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Beneficial impact of spironolactone in diabetic nephropathy.
Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Rossing P, Tarnow L, Parving HH. Schjoedt KJ, et al. Kidney Int. 2005 Dec;68(6):2829-36. doi: 10.1111/j.1523-1755.2005.00756.x. Kidney Int. 2005. PMID: 16316360 Clinical Trial.
Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease.
Nielsen SE, Schjoedt KJ, Rossing K, Persson F, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P. Nielsen SE, et al. Among authors: schjoedt kj. J Renin Angiotensin Aldosterone Syst. 2013 Jun;14(2):161-6. doi: 10.1177/1470320312460290. Epub 2012 Oct 29. J Renin Angiotensin Aldosterone Syst. 2013. PMID: 23108194 Free article. Clinical Trial.
Tubular and glomerular injury in diabetes and the impact of ACE inhibition.
Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P. Nielsen SE, et al. Among authors: schjoedt kj. Diabetes Care. 2009 Sep;32(9):1684-8. doi: 10.2337/dc09-0429. Epub 2009 Jun 5. Diabetes Care. 2009. PMID: 19502542 Free PMC article.
Long-term prevention of diabetic nephropathy: an audit.
Schjoedt KJ, Hansen HP, Tarnow L, Rossing P, Parving HH. Schjoedt KJ, et al. Diabetologia. 2008 Jun;51(6):956-61. doi: 10.1007/s00125-008-0990-3. Epub 2008 Apr 3. Diabetologia. 2008. PMID: 18385971
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page